No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
WGS250117C40000
- 0.00
- 0.000.00%
15min DelayTrading Dec 23 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest40.00Strike Price0.00Turnover173.34%IV-48.39%PremiumJan 17, 2025Expiry Date37.51Intrinsic Value100Multiplier25DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9507Delta0.0029Gamma2.05Leverage Ratio-0.0738Theta0.0244Rho1.95Eff Leverage0.0205Vega
Intraday
- 5D
- Daily
No Data
News
Institutional Investors Control 59% of GeneDx Holdings Corp. (NASDAQ:WGS) and Were Rewarded Last Week After Stock Increased 3.5%
GeneDx to Present at the 43rd Annual J.P. Morgan Healthcare Conference
GeneDx Holdings Corp. (NASDAQ:WGS): Is Breakeven Near?
GeneDx Announces Biogen, Praxis Precision Medicines And Stoke Therapeutics As The Founding Partners To Its Patient Access Program For Pediatric Epilepsy, Which Provides Access To Whole Exome Sequencing.
AppLovin, MicroStrategy, and 28 Other Stocks That Could Be Bubbles
Sleep Number, Getty Images, and More Stocks See Action From Activist Investors -- Barrons.com